SCD-1 inhibitors (iNovacia AB)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameSCD-1 inhibitors (iNovacia AB)
Drug Alias Namestearoyl-CoA-desaturase inhibitors (Swedish Orphan Biovitrum/iNovacia AB)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcyl-CoA desaturase inhibitors
TargetsAcyl-CoA desaturase
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2Skin Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSwedish Orphan Biovitrum Ab (Publ)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesiNovacia ABSwedish Orphan Biovitrum Ab (Publ)
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2Skin Diseases

Other Information

ATC CodeN/A
Related LinksN/A